A previous study proposed that higher IGF1 serum levels and lower IGFBP3 levels were associated with cancer risk [15]; however, the intra-individual variability in circulating IGF1, IGF2, and IGFBP3 levels is genetically determined [18]–[20]. This evidence concerns the gene IGF2 and cancer.